Search Results 651-660 of 17130 for treatment resistant depression
Study of Pomalidomide and Low Dose Dexamethasone With or Without Pembrolizumab (MK-3475) in Refractory or Relapsed and Refractory Multiple Myeloma (rrMM) (MK- ...
Nightmare disorder involves disturbing or scary dreams that awaken you, causing distress or preventing adequate sleep.
The primary purpose of this study is to assess the safety and effectiveness of ALLO-501A to treat patients with relapsed/refractory large B cell lymphoma (LBCL) ...
... Treat a Patient With Genetic Drug-Resistant Focal Epilepsy. ... EEG monitoring in the Intensive Care Unit. ... Crying with depressed affect induced by ...
The purpose of this study is to evaluate the effectiveness and safety of tazemetostat in combination with R2 in subjects with Relapsed/Refractory Follicular ...
About this study. Recent reports have identified a specific oncogenic mutation L265P of the MYD88 gene in approximately 30% of the patients with the ...
This is an international, multi-center, open-label, randomized, Phase III study in patients with metastatic TNBC refractory or relapsing after at least 2 prior ...
... refractory drug-resistant focal epilepsy. Epilepsy Behav Rep. 2022; 20:100570 Epub 2022 Nov 07. View PubMed; Alden EC, Pudumjee SB, Lundt ES, Albertson SM ...
... treatment of substance use disorders. ... Treatment outcomes of depression: the pharmacogenomic research network antidepressant medication pharmacogenomic study.
Anti-TNF therapy is costly and has several associated adverse effects. Therefore, the ability to identify patients whose IBD is refractory to this treatment can ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.